THERMO FISHER SCIEN - Dusseldorf Stock Exchang (TN8 DU) stock market data APIs
€559.17
0.17(0%)
as of February 6, 2025
THERMO FISHER SCIEN - Dusseldorf Stock Exchang Financial Data Overview
There is no Profile data available for TN8.DU.
Prev. Close
558.94
Open
559.17
High
558.81
Low
558.76
52 wk Range
471.4854-582.9
Market Cap
224 182 M
Shares Outstanding
0
Revenue
0
Dividends (Yield)
0.0021
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get THERMO FISHER SCIEN - Dusseldorf Stock Exchang data using free add-ons & libraries
Get THERMO FISHER SCIEN - Dusseldorf Stock Exchang Fundamental Data
THERMO FISHER SCIEN - Dusseldorf Stock Exchang Fundamental data includes:
- Net Revenue: 0
- EBITDA: 0
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get THERMO FISHER SCIEN - Dusseldorf Stock Exchang Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: 2025-01-31
- EPS/Forecast: NaN
Get THERMO FISHER SCIEN - Dusseldorf Stock Exchang End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
THERMO FISHER SCIEN - Dusseldorf Stock Exchang News
New
Thermo Fisher Scientific Full Year 2024 Earnings: EPS Beats Expectations
Thermo Fisher Scientific (NYSE:TMO) Full Year 2024 Results Key Financial Results Revenue: US$42.9b (flat on FY 2023). Net income: US$6.34b (up 5.7% from FY 2023). Profit margin: 15% (in line with FY...
Thermo Fisher Scientific Accelerates 100 Percent Renewable Electricity Goal for European Operations with New Solar Power Agreement with X-ELIO
Company leads value chain partners in purchase agreement that adds 118 megawatts (MW) of solar energy to enable decarbonization across the pharmaceutical and healthcare industries WALTHAM, Mass., Feb...
Raymond James downgrades Danaher on murky growth outlook
Investing.com -- Raymond James downgraded Danaher Corporation (NYSE:DHR) to "Market Perform" from "Outperform," citing concerns over the company's growth trajectory following its fourth-quarter result...
Is Thermo Fisher Scientific (TMO) the Best Cancer Stock to Buy According to Hedge Funds?
We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE:TMO) stands against...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
